Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
FAGR.BRthis companyFagron N.V.	€24.65	17.04×	2.82×	1.63×	10.03×	96.4%	21.5%	14.6%	9.6%	16.5%	10.5%	7.3%	0.85×	1.55×	4.27×	2.11×	1.7%	5	2.62	3	B+
ALEMS.BREuropean Medical Solutions	€3.40	12.09×	1.82×	0.44×	7.5×	-715.8%	32.9%	5.4%	3.7%	15.3%	7.4%	11.3%	1.58×	2.94×	3.63×	1.43×	0.0%	5	1.72	3	B
ARARGX.BRargenx SE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
CYAD.BRCelyad Oncology S.A.	€0.18	8.76×	2.99×	346.32×	-0.79×	-77.4%	9195.2%	-34200.0%	3952.4%	34.1%	366.4%	-94.9%	0×	0.24×	-112.22×	1.92×	0.0%	4	-221.13	4	A-
HYL.BRHyloris Pharmaceuticals S.A.	€4.25	-29.74×	7.11×	26.14×	-20.46×	-236.5%	82.0%	-129.5%	-87.9%	-23.9%	-30.8%	-3.5%	0.06×	1.4×	-12.63×	3.89×	0.0%	2	8.47	1	D+
ONONWD.BROnward Medical N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	8.76×	2.99×	26.14×	-0.79×	-236.5%	82.0%	-129.5%	3.7%	15.3%	7.4%	-3.5%	0.06×	1.4×	-12.63×	1.92×	0.0%	4	1.72	3	—